Nov 12, 2018 6:00 am EST CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Oct 22, 2018 4:00 am EDT CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Sep 21, 2018 4:10 pm EDT CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update
Aug 28, 2018 7:00 am EDT CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Jun 26, 2018 5:55 am EDT CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs
Jun 19, 2018 7:55 am EDT CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board
